| scholarly article | Q13442814 |
| P2093 | author name string | Terje Osnes | |
| Amy Østertun Geirdal | |||
| Ralph Dollner | |||
| Sinan Dheyauldeen | |||
| Liv Sofie Vartdal | |||
| P2860 | cites work | Management of epistaxis in hereditary hemorrhagic telangiectasia by Nd:YAG laser and quality of life assessment using the HR-QoL questionnaire | Q33212390 |
| The impact of septodermoplasty and potassium-titanyl-phosphate (KTP) laser therapy in the treatment of hereditary hemorrhagic telangiectasia-related epistaxis | Q33328736 | ||
| The effect of bevacizumab (Avastin) treatment on epistaxis in hereditary hemorrhagic telangiectasia | Q33405788 | ||
| Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). | Q33897059 | ||
| Efficiency of laser treatment in patients with hereditary hemorrhagic telangiectasia | Q33943392 | ||
| A retrospective analysis of low dose, intranasal injected bevacizumab (Avastin) in hereditary haemorrhagic telangiectasia | Q33976779 | ||
| Hereditary haemorrhagic telangiectasia: Pathophysiology, diagnosis and treatment | Q34024081 | ||
| Hereditary haemorrhagic telangiectasia (Osler-Weber-Rendu syndrome): a view from the 21st century. | Q35059330 | ||
| Hereditary hemorrhagic telangiectasia: an update on clinical manifestations and diagnostic measures | Q36480144 | ||
| Efficacy of intranasal Bevacizumab (Avastin) treatment in patients with hereditary hemorrhagic telangiectasia-associated epistaxis | Q37846178 | ||
| Safety of intranasal Bevacizumab (Avastin) treatment in patients with hereditary hemorrhagic telangiectasia-associated epistaxis | Q37846182 | ||
| Health-related quality of life in hereditary hemorrhagic telangiectasia | Q42619248 | ||
| Impact of genotype and mutation type on health-related quality of life in patients with hereditary hemorrhagic telangiectasia | Q46316673 | ||
| Cross-cultural comparisons of the content of SF-36 translations across 10 countries: results from the IQOLA Project. International Quality of Life Assessment | Q47743496 | ||
| An epistaxis severity score for hereditary hemorrhagic telangiectasia | Q48906632 | ||
| The natural history of epistaxis in patients with hereditary hemorrhagic telangiectasia in the Norwegian population: a cross-sectional study. | Q51429301 | ||
| Health-related quality of life in a rare disease: hereditary hemorrhagic telangiectasia (HHT) or Rendu-Osler-Weber disease. | Q51934035 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | nosebleed | Q202013 |
| bevacizumab | Q413299 | ||
| hereditary hemorrhagic telangiectasia | Q776881 | ||
| P304 | page(s) | 1210-1214 | |
| P577 | publication date | 2012-05-07 | |
| P1433 | published in | The Laryngoscope | Q15755068 |
| P1476 | title | Bevacizumab in hereditary hemorrhagic telangiectasia-associated epistaxis: effectiveness of an injection protocol based on the vascular anatomy of the nose | |
| P478 | volume | 122 |
| Q46283167 | Bevacizumab in the treatment of hereditary hemorrhagic telangiectasia. |
| Q38367321 | Evidence-based management of epistaxis in hereditary haemorrhagic telangiectasia |
| Q47941894 | Hereditary haemorrhagic telangiectasia: to transplant or not to transplant - is there a right time for liver transplantation? |
| Q87403186 | Intranasal submucosal bevacizumab for epistaxis in hereditary hemorrhagic telangiectasia: a double-blind, randomized, placebo-controlled trial |
| Q33957962 | Molecular pathways: can activin-like kinase pathway inhibition enhance the limited efficacy of VEGF inhibitors? |
| Q48187031 | Osteonecrosis after intranasal injection with bevacizumab in treating hereditary hemorrhagic telangiectasia: A case report |
| Q37602295 | Quality of life in patients with hereditary haemorrhagic telangiectasia (HHT) |
| Q38354161 | Successful management of chronic gastrointestinal hemorrhage using bevacizumab in the setting of hereditary hemorrhagic telangiectasia |
| Q49826259 | Vascular deficiency of Smad4 causes arteriovenous malformations: a mouse model of Hereditary Hemorrhagic Telangiectasia |
Search more.